Fumakilla Gestione

Gestione criteri di controllo 2/4

Fumakilla Il CEO è Kazuaki Ohshita, nominato in Apr2005, ha un mandato di 19.58 anni. possiede direttamente 1.67% delle azioni della società, per un valore di ¥ 291.77M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.4 anni e 6.4 anni.

Informazioni chiave

Kazuaki Ohshita

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	19.6yrs
Proprietà del CEO	1.7%
Durata media del management	4.4yrs
Durata media del Consiglio di amministrazione	6.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Kazuaki Ohshita (66 yo)

19.6yrs

Mandato

Mr. Kazuaki Oshimo has been President and CEO at Fumakilla Ltd. since April 2005 and serves as its Chairman. Mr. Oshimo served as General Manager of Operations Division at Fumakilla Ltd.since June 1998. M...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Kazuaki Ohshita	Chairman	19.6yrs	Nessun dato	1.67% ¥ 291.8m
Hiroaki Inoue	GM of Production Headquarters	12.5yrs	Nessun dato	0.091% ¥ 15.9m
Keizo Chikaraishi	MD & Director	2.4yrs	Nessun dato	Nessun dato
Toshiaki Muramoto	MD, GM of International Headquarters & International Planning Department and Director	2.4yrs	Nessun dato	0.061% ¥ 10.6m
Kazuya Gohara	Head of Management & Director	no data	Nessun dato	0.018% ¥ 3.2m
Takahiko Kato	Senior MD	4.4yrs	Nessun dato	0.073% ¥ 12.7m
Guan Tan	MD & Director	2.4yrs	Nessun dato	Nessun dato
Masakazu Doi	Deputy GM of Domestic Sales Headquarters	4.4yrs	Nessun dato	0.0061% ¥ 1.1m

4.4yrs

Durata media

62yo

Età media

Gestione esperta: Il team dirigenziale di 4998 è considerato esperto (durata media dell'incarico 4.4 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Kazuaki Ohshita	Chairman	23.4yrs	Nessun dato	1.67% ¥ 291.8m
Hiroaki Inoue	GM of Production Headquarters	11.4yrs	Nessun dato	0.091% ¥ 15.9m
Keizo Chikaraishi	MD & Director	9.4yrs	Nessun dato	Nessun dato
Toshiaki Muramoto	MD, GM of International Headquarters & International Planning Department and Director	9.4yrs	Nessun dato	0.061% ¥ 10.6m
Kazuya Gohara	Head of Management & Director	4.4yrs	Nessun dato	0.018% ¥ 3.2m
Takahiko Kato	Senior MD	4.4yrs	Nessun dato	0.073% ¥ 12.7m
Guan Tan	MD & Director	2.4yrs	Nessun dato	Nessun dato
Masakazu Doi	Deputy GM of Domestic Sales Headquarters	4.4yrs	Nessun dato	0.0061% ¥ 1.1m
Yoshinobu Nakano	Independent Outside Director	8.4yrs	Nessun dato	0.030% ¥ 5.3m
Yasutoshi Takei	Independent Outside Director	4.4yrs	Nessun dato	Nessun dato
Yukio Tanabe	Chairman of Audit & Supervisory Board	8.4yrs	Nessun dato	0.024% ¥ 4.2m
Masahiro Furuya	Independent Outside Director	3.4yrs	Nessun dato	0.012% ¥ 2.1m

6.4yrs

Durata media

66.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 4998 sono considerati esperti (durata media dell'incarico 6.4 anni).

Fumakilla Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Fumakilla Limited, Annual General Meeting, Jun 27, 2024

Fumakilla Limited, Annual General Meeting, May 15, 2023

No independent directors

Fumakilla Limited, Annual General Meeting, Jun 24, 2022

No independent directors

Recent updates

Second quarter 2025 earnings released: EPS: JP¥2.00 (vs JP¥24.33 in 2Q 2024)

Fumakilla Limited to Report Q2, 2025 Results on Nov 08, 2024

First quarter 2025 earnings released: EPS: JP¥43.02 (vs JP¥30.10 in 1Q 2024)

Fumakilla Limited to Report Q1, 2025 Results on Aug 09, 2024

Consensus EPS estimates fall by 13%, revenue upgraded

Price target increased by 14% to JP¥1,500

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

New major risk - Revenue and earnings growth

Fumakilla Limited, Annual General Meeting, Jun 27, 2024

Fumakilla Limited to Report Fiscal Year 2024 Results on May 15, 2024

Upcoming dividend of JP¥22.00 per share

Third quarter 2024 earnings released: JP¥52.18 loss per share (vs JP¥81.55 loss in 3Q 2023)

Third quarter 2024 earnings released: JP¥52.18 loss per share (vs JP¥81.55 loss in 3Q 2023)

Fumakilla Limited to Report Q3, 2024 Results on Feb 09, 2024

Second quarter 2024 earnings released: EPS: JP¥24.33 (vs JP¥7.34 in 2Q 2023)

Fumakilla Limited to Report Q2, 2024 Results on Nov 10, 2023

Consensus EPS estimates fall by 17%

First quarter 2024 earnings released: EPS: JP¥30.10 (vs JP¥28.03 in 1Q 2023)

Now 24% undervalued

Fumakilla Limited to Report Q1, 2024 Results on Aug 10, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

Fumakilla Limited, Annual General Meeting, May 15, 2023

Upcoming dividend of JP¥22.00 per share at 2.1% yield

Third quarter 2023 earnings released: JP¥81.54 loss per share (vs JP¥46.84 loss in 3Q 2022)

Fumakilla Limited to Report Q3, 2023 Results on Feb 10, 2023

Consensus forecasts updated

Second quarter 2023 earnings released: EPS: JP¥7.34 (vs JP¥4.19 in 2Q 2022)

No independent directors

Second quarter 2023 earnings released: EPS: JP¥7.34 (vs JP¥4.19 in 2Q 2022)

Fumakilla Limited to Report Q2, 2023 Results on Nov 11, 2022

Consensus EPS estimates fall by 19%

First quarter 2023 earnings released: EPS: JP¥28.03 (vs JP¥69.66 in 1Q 2022)

Fumakilla Limited to Report Q1, 2023 Results on Aug 09, 2022

Consensus forecasts updated

Fumakilla Limited, Annual General Meeting, Jun 24, 2022

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased to JP¥1,700

No independent directors

Fumakilla Limited to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥20.00 per share

Consensus forecasts updated

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Fumakilla Limited (TSE:4998) agreed to acquire 80% stake in Zapi Industrie Chimiche Spa.

Consensus EPS estimates fall to JP¥118

Price target decreased to JP¥2,120

Second quarter 2022 earnings released: EPS JP¥4.19 (vs JP¥10.80 in 2Q 2021)

First quarter 2022 earnings released: EPS JP¥69.65 (vs JP¥87.49 in 1Q 2021)

Consensus forecasts updated

Price target decreased to JP¥2,530

Full year 2021 earnings released: EPS JP¥141 (vs JP¥46.72 in FY 2020)

Idemitsu Kosan Co.,Ltd. (TSE:5019) entered into Share Exchange Agreement to acquire reaming 30.3% stake in SDS Biotech K.K. (TSE:4952) from group of sellers for ¥3.1 billion.

Upcoming dividend of JP¥22.00 per share

Third quarter 2021 earnings released: JP¥0.36 loss per share (vs JP¥41.68 loss in 3Q 2020)

New 90-day high: JP¥1,738

New 90-day high: JP¥1,722

Fumakilla Limited to Report Q3, 2021 Results on Feb 12, 2021

Analysts increase EPS estimates to JP¥164

Price target raised to JP¥2,860

Fumakilla Limited to Report Q2, 2021 Results on Nov 13, 2020

Fumakilla Limited to Report Q1, 2021 Results on Aug 07, 2020

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media